Physician

Kristian Delgado, M.D.

According to 2025 Medicare claims, Kristian Delgado, M.D. (NPI: 1033300256) practices pain management in the Killeen-Temple, TX market, with the plurality of this provider's patient population coming from Bell, TX. This provider's primary affiliated billing organization is INTEGRATED PAIN ASSOCIATES PLLC (NPI: 1689800419; TIN: 900491630) and primary practice location at 76542-3340. Delgado is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Delgado's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 780 traditional Medicare patients, billed 5,815 HCPCS/CPT codes, and received $399,265 in Medicare payments. The top billing code was G0482 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 2,580 prescription claims across 821 beneficiaries totaling $93,803 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). 2021 DME data shows 16 claims. Open Payments data shows 157 records totaling $5,846. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $221,708 to $399,265. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $157,531 to $93,803. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	473	7,627	$221,708
2016	1,090	5,149	$327,107
2017	956	4,388	$276,583
2018	1,273	7,397	$536,836
2019	1,444	8,679	$556,807
2020	1,047	6,634	$425,866
2021	1,127	9,925	$781,294
2022	1,037	8,793	$610,108
2023	857	6,520	$407,663
2024	780	5,815	$399,265

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	705	2,098	$157,531
2016	1,483	5,523	$435,772
2017	922	2,022	$193,749
2018	530	1,548	$85,855
2019	547	1,322	$74,310
2020	552	1,357	$43,951
2021	856	2,739	$106,438
2022	743	2,793	$89,155
2023	791	2,659	$79,440
2024	821	2,580	$93,803

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	13	$89
2020	16	16	$13,040
2021	16	16	$11,820
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	218	272	$193
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	93	104	$153
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	547	1,225	$84
64493	Injection of lower or sacral spine facet joint using imaging guidance, single level	89	114	$72
80307	Testing for presence of drug, by chemistry analyzers	288	385	$60

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	1,069	29,726	$30,013
Belbuca	Buprenorphine Hcl	13	390	$10,461
Buprenorphine	Buprenorphine	34	954	$9,864
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	238	6,643	$7,698
Pregabalin	Pregabalin	293	10,063	$6,429

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	157	$5,846	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kristian Delgado, M.D.?

Tedicare shows public-source Medicare data for Kristian Delgado, M.D. (NPI 1033300256), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kristian Delgado, M.D. have ACO affiliation data?

Kristian Delgado, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Kristian Delgado, M.D.?

Kristian Delgado, M.D. is linked to INTEGRATED PAIN ASSOCIATES PLLC (billing NPI 1689800419) in the available physician profile data.

Does Kristian Delgado, M.D. have Open Payments data?

Kristian Delgado, M.D. has 157 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.